13.04.2015 Views

Kantar Health National Health and Wellness Survey in Brazil Fact ...

Kantar Health National Health and Wellness Survey in Brazil Fact ...

Kantar Health National Health and Wellness Survey in Brazil Fact ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

The catalyst for<br />

successful decision<br />

-mak<strong>in</strong>g <strong>in</strong> the life<br />

sciences <strong>in</strong>dustry<br />

At a glance<br />

Clients have used <strong>Kantar</strong> <strong>Health</strong>’s<br />

<strong>National</strong> <strong>Health</strong> <strong>and</strong> <strong>Wellness</strong> <strong>Survey</strong><br />

database for:<br />

• Quantify<strong>in</strong>g leverage po<strong>in</strong>ts<br />

• Portfolio plann<strong>in</strong>g<br />

• Patient ecosystem<br />

• Penetration analyses<br />

• Patient <strong>and</strong> Rx forecast<strong>in</strong>g <strong>in</strong>puts<br />

• Message plann<strong>in</strong>g to physicians<br />

<strong>and</strong> payers<br />

• Unmet needs analysis<br />

• Acquisition: Go/no-go decision<br />

support<br />

• Hypothesis creation <strong>and</strong> validation<br />

• Early development optimization<br />

• PRO creation <strong>and</strong> validation<br />

• Predictive analysis: F<strong>in</strong>d<strong>in</strong>g<br />

nonobvious drivers<br />

Why <strong>Kantar</strong> <strong>Health</strong>?<br />

<strong>Kantar</strong> <strong>Health</strong> is a global, evidence-based<br />

decision support partner to the world’s<br />

lead<strong>in</strong>g pharmaceutical, biotech, device<br />

<strong>and</strong> diagnostic companies. Our 700+<br />

staff <strong>in</strong> over 40 countries act as catalysts,<br />

br<strong>in</strong>g<strong>in</strong>g together cl<strong>in</strong>ical, medical <strong>and</strong><br />

methodological expertise, commercial/<br />

market<strong>in</strong>g know-how <strong>and</strong> proprietary data.<br />

It is this rare comb<strong>in</strong>ation, together with<br />

our unparalleled stakeholder reach, that<br />

enables us to mobilize <strong>in</strong>cisive, imag<strong>in</strong>ative<br />

<strong>and</strong> timely ROI-driven solutions,<br />

empower<strong>in</strong>g clients to deliver better<br />

healthcare options to their customers.<br />

<strong>National</strong> <strong>Health</strong> <strong>and</strong><br />

<strong>Wellness</strong> <strong>Survey</strong><br />

Patient-Reported Outcomes <strong>in</strong> <strong>Brazil</strong><br />

<strong>Kantar</strong> <strong>Health</strong>’s <strong>National</strong> <strong>Health</strong> <strong>and</strong><br />

<strong>Wellness</strong> <strong>Survey</strong> (NHWS), the largest<br />

<strong>in</strong>ternational self-reported patient database<br />

<strong>in</strong> the healthcare <strong>in</strong>dustry, is now available <strong>in</strong><br />

<strong>Brazil</strong>, the largest market <strong>in</strong> Lat<strong>in</strong> America.<br />

The NHWS began collect<strong>in</strong>g survey<br />

responses <strong>in</strong> <strong>Brazil</strong> <strong>in</strong> 2011 utiliz<strong>in</strong>g a mixed<br />

recruit<strong>in</strong>g methodology (Internet/CAWI) to<br />

ensure representativeness of the population.<br />

The database offers a holistic view of the<br />

patient <strong>in</strong> <strong>Brazil</strong>, from the patient’s po<strong>in</strong>t<br />

of view, <strong>and</strong> reports metrics that can only<br />

be captured from the patient. This realworld<br />

patient-level <strong>in</strong>formation has the<br />

advantage of be<strong>in</strong>g able to compare<br />

data to key established markets: the US,<br />

Europe (France, Germany, Italy, Spa<strong>in</strong> <strong>and</strong><br />

the UK) <strong>and</strong> Japan.<br />

The survey was completed by 12,000<br />

<strong>Brazil</strong>ian consumers. Topics covered <strong>in</strong>clude<br />

health status, attitudes, behaviors <strong>and</strong><br />

outcomes among adults 18 or older. The<br />

survey also captures <strong>in</strong>formation unique to<br />

the <strong>Brazil</strong>ian market, <strong>in</strong>clud<strong>in</strong>g:<br />

• Use of national health <strong>in</strong>surance<br />

(Sistema Unico de Saude)<br />

• Whether patients have paid out of pocket<br />

for a br<strong>and</strong>-name medication<br />

• Where patients received their <strong>in</strong>itial<br />

written prescription<br />

• Socioeconomic level<br />

Data is captured for respondents suffer<strong>in</strong>g<br />

from or show<strong>in</strong>g symptoms of more than<br />

165 conditions, <strong>in</strong>clud<strong>in</strong>g but not limited to:<br />

• Autoimmune Conditions<br />

• Cancer<br />

• Gastro<strong>in</strong>test<strong>in</strong>al Conditions<br />

• Infectious Diseases<br />

• Metabolic Conditions<br />

• Muscoloskeletal Conditions<br />

• Neurological Conditions<br />

• Ophthalmic Conditions<br />

• Pa<strong>in</strong><br />

• Psychiatric Conditions<br />

• Respiratory Conditions<br />

• Urologic Conditions<br />

Contact Us:<br />

For more <strong>in</strong>formation on how the<br />

<strong>National</strong> <strong>Health</strong> <strong>and</strong> <strong>Wellness</strong> <strong>Survey</strong><br />

can help you get it right the first time<br />

<strong>in</strong> emerg<strong>in</strong>g markets, please contact<br />

nhws@kantarhealth.com.<br />

www.kantarhealth.com


NHWS Offers Advantages over Other Databases <strong>and</strong> Sources<br />

Broad Market Coverage • Represents the general population <strong>and</strong> <strong>in</strong>cludes a “healthy population” comparator<br />

• Includes patients not see<strong>in</strong>g their doctor, not treat<strong>in</strong>g with an Rx, or OTC self-treated<br />

Detailed Patient<br />

Information<br />

Ability to Recontact<br />

Patients<br />

Flexible, Consistent <strong>and</strong><br />

Reusable Database<br />

• Can be used by forecast<strong>in</strong>g, new product <strong>and</strong> licens<strong>in</strong>g teams for market potential: full prevalence <strong>and</strong> <strong>in</strong>cidence<br />

of disease<br />

• Can do cross-condition analyses: overlapp<strong>in</strong>g cardiovascular conditions, obesity, respiratory conditions, cancers<br />

• Can do comprehensive “at risk” analyses, <strong>in</strong>clud<strong>in</strong>g <strong>in</strong>dividual <strong>and</strong> family health history, current health state <strong>and</strong><br />

lifestyle considerations<br />

• Has the ability to run analysis on specific segments <strong>and</strong> to fill <strong>in</strong> market maps <strong>and</strong> customer segments <strong>and</strong><br />

profiles with more than 11,000 key metrics cover<strong>in</strong>g Attitudes, Behaviors, Characteristics <strong>and</strong> Demographics<br />

• Conta<strong>in</strong>s validated scales that can derive various populations; measure gap between patient perception of<br />

severity <strong>and</strong> cl<strong>in</strong>ical derived severity; <strong>and</strong> quantify the burden of illness through patient-reported outcomes of<br />

quality of life, productivity, comorbidity <strong>and</strong> healthcare resource utilization impact<br />

• Provides more than 400 publications worldwide<br />

• Has the ability to recontact patients with a proprietary survey to provide a richer dataset of <strong>in</strong>formation,<br />

supplemented by answers previously given <strong>in</strong> NHWS<br />

• Can profile <strong>and</strong> recontact caregivers of relevant diseases <strong>and</strong> create <strong>and</strong> validate proprietary measurement<br />

<strong>in</strong>struments for future cl<strong>in</strong>ical trials<br />

• Allows cont<strong>in</strong>uous analysis of more than 11,000 key patient-reported metrics—bivariate or multivariate<br />

• Can be leveraged by market<strong>in</strong>g, market research, new products, bus<strong>in</strong>ess development, forecast<strong>in</strong>g, consumer<br />

market<strong>in</strong>g, public <strong>and</strong> <strong>in</strong>vestor relations, medical affairs, economic affairs, epidemiology, <strong>and</strong> health economics<br />

<strong>and</strong> outcomes research<br />

• Is more economical—less duplication of spend<strong>in</strong>g<br />

• Provides cohesion <strong>and</strong> consistency across data source <strong>and</strong> strategic <strong>and</strong> portfolio plann<strong>in</strong>g, <strong>in</strong>clud<strong>in</strong>g multiple<br />

geographies<br />

NHWS Offers Large Sample Sizes across Broad Geographic Coverage<br />

Most recent sample size <strong>and</strong> <strong>in</strong>augural year<br />

www.kantarhealth.com<br />

KH NHWS <strong>Brazil</strong> <strong>Fact</strong> Sheet 2011.11.02

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!